This company listing is no longer active
0OPB Stock Overview
McKesson Europe AG provides logistics and other services to the pharmaceutical and healthcare sectors worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
McKesson Europe AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €24.20 |
| 52 Week High | €24.30 |
| 52 Week Low | €20.00 |
| Beta | 0.13 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | 8.04% |
| 3 Year Change | -6.56% |
| 5 Year Change | -8.33% |
| Change since IPO | -38.09% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0OPB | GB Healthcare | GB Market | |
|---|---|---|---|
| 7D | 0% | 1.3% | -0.7% |
| 1Y | 8.0% | -28.0% | -1.8% |
Return vs Industry: 0OPB underperformed the UK Healthcare industry which returned 17.4% over the past year.
Return vs Market: 0OPB exceeded the UK Market which returned 3% over the past year.
Price Volatility
| 0OPB volatility | |
|---|---|
| 0OPB Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.5% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0OPB has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 0OPB's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1835 | 6,808 | Sebastian Ring | www.mckesson.eu/mck-en |
McKesson Europe AG provides logistics and other services to the pharmaceutical and healthcare sectors worldwide. The company operates through two divisions, Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution division engages in the wholesale of pharmaceutical and other health care products.
McKesson Europe AG Fundamentals Summary
| 0OPB fundamental statistics | |
|---|---|
| Market cap | €4.96b |
| Earnings (TTM) | -€54.30m |
| Revenue (TTM) | €9.26b |
0.5x
P/S Ratio-91.3x
P/E RatioIs 0OPB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0OPB income statement (TTM) | |
|---|---|
| Revenue | €9.26b |
| Cost of Revenue | €8.46b |
| Gross Profit | €792.30m |
| Other Expenses | €846.60m |
| Earnings | -€54.30m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.27 |
| Gross Margin | 8.56% |
| Net Profit Margin | -0.59% |
| Debt/Equity Ratio | 0.3% |
How did 0OPB perform over the long term?
See historical performance and comparison